Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
03/20/2012 | US8140303 Bioequivalence evaluation method of evaluating bioequivalence of a generic drug to the corresponding original drug |
03/20/2012 | US8140271 Least-square deconvolution (LSD): a method to resolve DNA mixtures |
03/20/2012 | US8140269 Methods, computer-accessible medium, and systems for generating a genome wide haplotype sequence |
03/20/2012 | US8140268 Computational method for drug discovery and receptor design |
03/20/2012 | US8140267 System and method for identifying similar molecules |
03/20/2012 | US8139207 In vitro determination of analyte levels within body fluids |
03/20/2012 | US8138360 substrates for amyloidogenic proteins, for example, A beta 1-42, an amyloid protein, brain deposits of which are associated with Alzheimer's disease |
03/20/2012 | US8138323 Cytokines; side effect reduction; bactericides; antitumor agents; anticarcinogenic agents |
03/20/2012 | US8138322 Human T1R2 nucleic acid sequences and polypeptides |
03/20/2012 | US8138319 Sperm cell separation methods and compositions containing aptamers or nucleic acid sequences for use therein |
03/20/2012 | US8138314 Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulations |
03/20/2012 | US8138311 Modified proteins, designer toxins, and methods of making thereof |
03/20/2012 | US8138310 Chimeric CD154 polypeptides |
03/20/2012 | US8138307 Parkin interacting polypeptides and methods of use |
03/20/2012 | US8138154 Biglycan and related therapeutics and methods of use |
03/20/2012 | US8138141 HMG1 antibody for treating inflammatory conditions |
03/20/2012 | US8137994 Methods of identifying responders to dopamine agonist therapy and treating metabolic conditions thereof |
03/20/2012 | US8137993 Methods of identifying responders to dopamine agonist therapy and treating metabolic conditions thereof |
03/20/2012 | US8137992 Methods of identifying responders to dopamine agonist therapy and treating metabolic conditions thereof |
03/20/2012 | US8137991 Methods of reducing angiogenesis of age-related macular degeneration (AMD) or choroidal neovascularization by an anti-carboxyetheylpyrrole (CFP) antibody |
03/20/2012 | US8137990 Compositions for chemiluminescent detection of hydrogen peroxide |
03/20/2012 | US8137989 Method for delivering a cytokine using a colloidal metal |
03/20/2012 | US8137988 Fluidic force discrimination |
03/20/2012 | US8137987 Simultaneous assay for determining drugs |
03/20/2012 | US8137985 Polyelectrolytic internal calibration system of a flow-through assay |
03/20/2012 | US8137984 Caffeine detection via internally-referenced two part assay |
03/20/2012 | US8137980 On-board control for analytical elements |
03/20/2012 | US8137979 Preconcentrator device |
03/20/2012 | US8137978 Diagnostic method for biomarkers of adverse coronary events |
03/20/2012 | US8137977 Lipidomic approaches to determining drug response phenotypes in cardiovascular disease |
03/20/2012 | US8137976 Dual angle radiation scanning of objects |
03/20/2012 | US8137975 Method for a rapid antibody-based analysis of platelet populations |
03/20/2012 | US8137966 Rat embryonic stem cell |
03/20/2012 | US8137960 Bovine adeno-associated viral (BAAV) vector and uses thereof |
03/20/2012 | US8137934 Regeneration and neogenesis of retinal photoreceptor cell using Otx2 gene |
03/20/2012 | US8137925 Methods and compositions for protein labeling using lipoic acid ligases |
03/20/2012 | US8137924 Method and compositions for detecting botulinum neurotoxin |
03/20/2012 | US8137923 Glycoprotein VI and uses thereof |
03/20/2012 | US8137922 Method for diagnosing the metabolic syndrome (MS) |
03/20/2012 | US8137921 Homogeneous time resolved fluorescence based test system for Paramyxoviridae |
03/20/2012 | US8137920 Multi-wavelength analyses of sol-particle specific binding assays |
03/20/2012 | US8137915 Genes involved in intestinal inflammatory diseases and use thereof |
03/20/2012 | US8137908 Mesothelin vaccines and model systems |
03/20/2012 | US8137904 Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue |
03/20/2012 | US8137903 Method for magnetic separation of red blood cells from a patient sample |
03/20/2012 | US8137680 Analysis of saccharide vaccines without interference |
03/20/2012 | US8137675 Bont/a peptides and methodsof predicting and reducing immunoresistance to botulinum toxin therapy |
03/20/2012 | US8137668 Methods and compositions for generating human monoclonal antibodies |
03/20/2012 | US8137625 Urea sensor |
03/20/2012 | US8137616 System for multi color real time PCR |
03/20/2012 | US8137529 Methods of using an electrochemical biosensor |
03/20/2012 | US8136220 Method of making an electrochemical sensor |
03/20/2012 | CA2701341C Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex |
03/20/2012 | CA2650827C Diagnostic test unit with a container for test carriers |
03/20/2012 | CA2642482C Method of calculating quality parameters of foodstuffs |
03/20/2012 | CA2616439C Methods and systems for monitoring multiple optical signals from a single source |
03/20/2012 | CA2589197C Method and apparatus for ultrasonic determination of hematocrit and hemoglobin concentrations |
03/20/2012 | CA2570593C Genetically engineered pyrroloquinoline quinone dependent glucose dehydrogenase comprising an amino acid insertion |
03/20/2012 | CA2510515C Multi-phase fluid sampling method and apparatus |
03/20/2012 | CA2500409C Sheath based blood vessel puncture locator and depth indicator |
03/20/2012 | CA2498354C System and methods for electrophoretic separation of proteins on protein binding membranes |
03/20/2012 | CA2474801C Human monoclonal antibody fab fragments directed against hcv e2 glycoprotein and endowed with in vitro neutralizing activity |
03/20/2012 | CA2473513C Aggrecanase-1 and -2 peptide substrates and methods |
03/20/2012 | CA2471114C Mutant b-raf polypeptide and a use thereof in the diagnosis of cancer |
03/20/2012 | CA2468877C A method for determining the biological activity of defibrotide |
03/20/2012 | CA2455455C Method and system to determine revised dosage |
03/20/2012 | CA2453300C Chimeric chains that code for proteins that induce effects directed against viruses |
03/20/2012 | CA2432538C Method of disrupting interactions between biotin and biotin-binding compounds |
03/20/2012 | CA2429172C Novel mutant allergens |
03/20/2012 | CA2407876C Method for the detection of cytosine methylations |
03/20/2012 | CA2392453C Modulation of signal transduction |
03/20/2012 | CA2379564C Structural protein of adeno-associated virus with modified chromatographic properties, its production and use |
03/20/2012 | CA2363067C Compounds and methods to inhibit or augment an inflammatory response |
03/20/2012 | CA2360020C Methods for differentiating and monitoring parathyroid and bone status related diseases |
03/20/2012 | CA2299560C Human defensin def-x, gene and dnac, composition containing same and diagnostic and therapeutic applications |
03/20/2012 | CA2296842C Ligands, including antibodies, showing reactivity against endocrine cells |
03/20/2012 | CA2273622C Inhibition of nmda receptor signalling in reducing neuronal damage |
03/15/2012 | WO2012034132A2 Inhibitors of human ezh2, and methods of use thereof |
03/15/2012 | WO2012034123A1 Activating phosphorylation site on glutaminase c |
03/15/2012 | WO2012034117A2 Enzyme co-factor enhancement of biosensor performance |
03/15/2012 | WO2012034094A2 Integrated microfluidic radioassay and imaging platform for small sample analysis |
03/15/2012 | WO2012034061A2 Combination methods of diagnosing cancer in a patient |
03/15/2012 | WO2012034030A1 Variant annotation, analysis and selection tool |
03/15/2012 | WO2012033999A2 Biomarkers for predicting kidney and glomerular pathologies |
03/15/2012 | WO2012033993A2 Methods for assaying enzyme activities |
03/15/2012 | WO2012033953A1 Methods for assessing and identifying or evolving conditionally active therapeutic proteins |
03/15/2012 | WO2012033842A2 Methods, apparatuses and systems for collection of tissue sections |
03/15/2012 | WO2012033831A2 Methods and compositions for gamma-secretase assay |
03/15/2012 | WO2012033666A2 Electronic and fluidic interface |
03/15/2012 | WO2012033622A1 Determination of rock mechanics while slabbing |
03/15/2012 | WO2012033524A2 Control of dna movement in a nanopore at one nucleotide precision by a processive enzyme |
03/15/2012 | WO2012033459A1 Maturation of gastrointestinal tract |
03/15/2012 | WO2012033455A1 Air sampling device for exhaled breath utilizing collection of compounds and gases on to a suitable adsorbent device |
03/15/2012 | WO2012033446A1 Method for labeling of compounds |
03/15/2012 | WO2012033409A1 Optical trap, chip, sensor system and method for manufacturing an optical trap |
03/15/2012 | WO2012033407A2 Method for diagnosing colorectal cancer |
03/15/2012 | WO2012033382A2 Novel rna-binding protein and label-free detection method for detecting microrna using same |
03/15/2012 | WO2012033333A2 Method for detecting base dimers using gold nanoparticles, and a rapid screening method for substances which promote base dimer formation using the same |
03/15/2012 | WO2012033330A2 Measurement apparatus |
03/15/2012 | WO2012033291A2 Apparatus for separating fine particles using magnetophoresis, and method for separating fine particles using same |